NxThera
Medical device to improve urinary flow of men and develops patient quality of life.
Launch date
Employees
Market cap
-
Enterprise valuation
€278m (Public information from Mar 2018)
Maple Grove Minnesota (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $6.0m | Series A | |
$21.6m | Series B | ||
| N/A | $6.6m | Early VC | |
| N/A | $25.0m | Series C | |
| N/A | $3.0m | Debt | |
$40.0m | Series D | ||
| N/A | $15.3m | Series E | |
| N/A | $6.0m | Debt | |
$306m Valuation: $306m | Acquisition | ||
| Total Funding | €104m | ||
Related Content
Recent News about NxThera
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.